3-(4-chlorophenyl)-1-(oxolan-3-ylmethyl)pyrazolo[4,3-c]pyridine;3-(4-chlorophenyl)-1-[(3S)-oxolan-3-yl]pyrazolo[4,3-c]pyridine;3-(4-chlorophenyl)-1-(1-propan-2-ylpiperidin-4-yl)pyrazolo[4,3-c]pyridine
C53H53Cl3N10O2 — CID 159859036
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(4-chlorophenyl)-1-(oxolan-3-ylmethyl)pyrazolo[4,3-c]pyridine;3-(4-chlorophenyl)-1-[(3S)-oxolan-3-yl]pyrazolo[4,3-c]pyridine;3-(4-chlorophenyl)-1-(1-propan-2-ylpiperidin-4-yl)pyrazolo[4,3-c]pyridine
3-(4-chlorophenyl)-1-(oxolan-3-ylmethyl)pyrazolo[4,3-c]pyridine;3-(4-chlorophenyl)-1-[(3S)-oxolan-3-yl]pyrazolo[4,3-c]pyridine;3-(4-chlorophenyl)-1-(1-propan-2-ylpiperidin-4-yl)pyrazolo[4,3-c]pyridine (PubChem CID 159859036) has the molecular formula C53H53Cl3N10O2 and a molecular weight of 968.43 g/mol. Its IUPAC name is 3-(4-chlorophenyl)-1-(oxolan-3-ylmethyl)pyrazolo[4,3-c]pyridine;3-(4-chlorophenyl)-1-[(3S)-oxolan-3-yl]pyrazolo[4,3-c]pyridine;3-(4-chlorophenyl)-1-(1-propan-2-ylpiperidin-4-yl)pyrazolo[4,3-c]pyridine.
Molecular Properties
| Compound Name | 3-(4-chlorophenyl)-1-(oxolan-3-ylmethyl)pyrazolo[4,3-c]pyridine;3-(4-chlorophenyl)-1-[(3S)-oxolan-3-yl]pyrazolo[4,3-c]pyridine;3-(4-chlorophenyl)-1-(1-propan-2-ylpiperidin-4-yl)pyrazolo[4,3-c]pyridine |
|---|---|
| PubChem CID | 159859036 |
| Molecular Formula | C53H53Cl3N10O2 |
| Molecular Weight | 968.43 g/mol |
| Exact Mass | 966.34 |
| IUPAC Name | 3-(4-chlorophenyl)-1-(oxolan-3-ylmethyl)pyrazolo[4,3-c]pyridine;3-(4-chlorophenyl)-1-[(3S)-oxolan-3-yl]pyrazolo[4,3-c]pyridine;3-(4-chlorophenyl)-1-(1-propan-2-ylpiperidin-4-yl)pyrazolo[4,3-c]pyridine |
| SMILES | CC(C)N1CCC(n2nc(-c3ccc(Cl)cc3)c3cnccc32)CC1.Clc1ccc(-c2nn(CC3CCOC3)c3ccncc23)cc1.Clc1ccc(-c2nn([C@H]3CCOC3)c3ccncc23)cc1 |
| InChI | InChI=1S/C20H23ClN4.C17H16ClN3O.C16H14ClN3O/c1-14(2)24-11-8-17(9-12-24)25-19-7-10-22-13-18(19)20(23-25)15-3-5-16(21)6-4-15;18-14-3-1-13(2-4-14)17-15-9-19-7-5-16(15)21(20-17)10-12-6-8-22-11-12;17-12-3-1-11(2-4-12)16-14-9-18-7-5-15(14)20(19-16)13-6-8-21-10-13/h3-7,10,13-14,17H,8-9,11-12H2,1-2H3;1-5,7,9,12H,6,8,10-11H2;1-5,7,9,13H,6,8,10H2/t;;13-/m..0/s1 |
| InChIKey | NQXAHSZBFGAMSA-LZVLKHNHSA-N |
| XLogP | 12.30 |
| TPSA | 113.83 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 68 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 968.43 |
| LogP ≤ 5 | 12.30 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159859036 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.